Phenylketonuria Treatment
33 places
Worldwide report
Every place
- 33Reports naming them
- 1Markets they lead in
- 33Regions & countries
- 1Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Homology Medicines or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Where they show up
33 reportsOur reports that name Homology Medicines as a key player, by category and place.
- Pharmaceuticals · 33
Places 33
- Africa 1
- APAC 1
- Australia 1
- Brazil 1
- Canada 1
- China 1
- Ecuador 1
- Egypt 1
- Europe 1
France 1- Germany 1
- Global 1
Hong Kong 1
India 1
Italy 1
Japan 1
Kenya 1- Latin America 1
Malaysia 1
Mexico 1- Middle East 1
New Zealand 1- North America 1
Philippines 1
Russia 1
Saudi Arabia 1
Singapore 1
South Africa 1
Spain 1
Thailand 1- UAE 1
UK 1
US 1
Homology Medicines's markets
1Markets where they are a key player. Each opens the market's statistics for every place we cover.
Pharmaceuticals1
None of their markets match.
Recent reports naming Homology Medicines
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
33 places
Companies they compete with most
Named as key players in the same markets as Homology Medicines (number of shared markets).
Ajinomoto Co1 shared market
BioMarin1 shared market
Nestle1 shared market
PTC Therapeutics1 shared market
Free public data on Homology Medicines
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Clinical trials
1 active study led by Homology Medicines, of 5 in all
Source: ClinicalTrials.gov, Studies with Homology Medicines (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Trials over time
Studies Homology Medicines leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Homology Medicines or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Topics
The topics of the markets Homology Medicines is in.
From our blog
Stories on the topics Homology Medicines works in.
Bone and Joint Health: Supplements for an Ageing Population
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Eye Health Supplements: Screens, Ageing and Vision
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Herbal Supplements: Quality, Safety and Trust
170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Read